0.3751
price up icon0.81%   0.0056
 
loading
Precedente Chiudi:
$0.3695
Aprire:
$0.3691
Volume 24 ore:
378.76K
Relative Volume:
0.19
Capitalizzazione di mercato:
$15.37M
Reddito:
$62.71M
Utile/perdita netta:
$-10.48M
Rapporto P/E:
-0.5954
EPS:
-0.63
Flusso di cassa netto:
$-13.77M
1 W Prestazione:
+16.26%
1M Prestazione:
+12.64%
6M Prestazione:
-52.59%
1 anno Prestazione:
-92.77%
Intervallo 1D:
Value
$0.3541
$0.3868
Intervallo di 1 settimana:
Value
$0.3202
$0.395
Portata 52W:
Value
$0.2179
$5.19

Prophase Labs Inc Stock (PRPH) Company Profile

Name
Nome
Prophase Labs Inc
Name
Telefono
(215) 345-0919
Name
Indirizzo
711 STEWART AVE, SUITE 200, NEW YORK, PA
Name
Dipendente
96
Name
Cinguettio
Name
Prossima data di guadagno
2025-05-20
Name
Ultimi documenti SEC
Name
PRPH's Discussions on Twitter

Confronta PRPH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
PRPH
Prophase Labs Inc
0.3701 14.95M 62.71M -10.48M -13.77M -0.63
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
396.38 152.34B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
188.98 135.39B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
514.45 41.54B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
110.89 31.59B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
138.97 24.31B 15.50B 1.33B 2.16B 7.34

Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-12-20 Iniziato H.C. Wainwright Buy
2021-10-13 Downgrade Dawson James Buy → Neutral
2021-01-20 Iniziato Dawson James Buy

Prophase Labs Inc Borsa (PRPH) Ultime notizie

pulisher
May 23, 2025

ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Call Transcript - MSN

May 23, 2025
pulisher
May 21, 2025

ProPhase Labs’ Earnings Call: Strategic Moves Amid Challenges - TipRanks

May 21, 2025
pulisher
May 21, 2025

ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strat - GuruFocus

May 21, 2025
pulisher
May 20, 2025

ProPhase Labs Reports Q1 2025 Earnings and Strategic Developments - TipRanks

May 20, 2025
pulisher
May 20, 2025

Transcript : ProPhase Labs, Inc., Q1 2025 Earnings Call, May 20, 2025 - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

ProPhase Labs, Inc. SEC 10-Q Report - TradingView

May 20, 2025
pulisher
May 20, 2025

Earnings call transcript: ProPhase Labs beats Q1 2025 EPS forecast, stock rises - Investing.com

May 20, 2025
pulisher
May 20, 2025

ProPhase Labs earnings beat by $0.05, revenue fell short of estimates - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

Prophase Labs Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 20, 2025
pulisher
May 20, 2025

ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

ProPhase (PRPH) Awaits Potential $50 Million Insurance Recovery - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ProPhase (PRPH) Awaits Potential $50 Million Insurance Recovery | PRPH Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ProPhase (PRPH) Explores Strategic Sale of Nebula Genomics | PRPH Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ProPhase Labs (PRPH) Anticipates Extension for Nasdaq Listing | PRPH Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

PRPH Streamlines Operations with Strategic Changes | PRPH Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ProPhase Labs Announces Financial Results for the Three Months E - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ProPhase Labs Inc Reports Q1 2025 EPS of $(0.13) and Revenue of $1.4 Million, Missing Estimates - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ProPhase Labs (PRPH) Focuses on Strategic Growth Amid Revenue De - GuruFocus

May 20, 2025
pulisher
May 20, 2025

PROPHASE LABS Earnings Results: $PRPH Reports Quarterly Earnings - Nasdaq

May 20, 2025
pulisher
May 20, 2025

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 | PRPH Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

ProPhase Labs Slashes Costs by $8M, Reveals Three Major Value Drivers Including Potential $50M Collection - Stock Titan

May 20, 2025
pulisher
May 16, 2025

ProPhase Labs Delays Form 10-Q Filing - TipRanks

May 16, 2025
pulisher
May 13, 2025

ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 - GlobeNewswire

May 13, 2025
pulisher
May 07, 2025

ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Bought by Renaissance Technologies LLC - Defense World

May 07, 2025
pulisher
May 06, 2025

ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - MSN

May 06, 2025
pulisher
May 05, 2025

Geode Capital Management LLC Boosts Stake in ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World

May 05, 2025
pulisher
May 02, 2025

PRPH’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

There is no doubt that ProPhase Labs Inc (PRPH) ticks all the boxes. - Sete News

May 02, 2025
pulisher
May 01, 2025

Metric Analysis: ProPhase Labs Inc (PRPH)’s Key Ratios in the Limelight - DWinneX

May 01, 2025
pulisher
May 01, 2025

What was ProPhase Labs Inc (PRPH)’s performance in the last session? - uspostnews.com

May 01, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 24, 2025

ProPhase Labs Inc (PRPH) is a good investment, but the stock may be overvalued - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Daily Market Movement: ProPhase Labs Inc (PRPH) Sees a 0.54 Increase, Closing at 0.35 - DWinneX

Apr 24, 2025
pulisher
Apr 23, 2025

Monitoring ProPhase Labs Inc (PRPH) after recent insider movements - knoxdaily.com

Apr 23, 2025
pulisher
Apr 22, 2025

ProPhase Labs Inc (PRPH) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Investors Take Advantage Of 7.67% Gain In ProPhase Labs Inc (NASDAQ: PRPH) - Stocksregister

Apr 22, 2025
pulisher
Apr 22, 2025

Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN

Apr 22, 2025
pulisher
Apr 18, 2025

ProPhase Labs, Inc. (NASDAQ:PRPH) Short Interest Up 50.0% in March - Defense World

Apr 18, 2025
pulisher
Apr 16, 2025

ProPhase Labs Closes $23.6M Asset Sale to Streamline Business Strategy - citybuzz -

Apr 16, 2025
pulisher
Apr 15, 2025

ProPhase Labs Inc (NASDAQ: PRPH): Forecast Weak In 2025, Up -95.29% - Stocksregister

Apr 15, 2025
pulisher
Apr 04, 2025

HighTower Advisors LLC Acquires 57,736 Shares of ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World

Apr 04, 2025
pulisher
Apr 04, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Apr 04, 2025
pulisher
Apr 03, 2025

ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges By GuruFocus - Investing.com Canada

Apr 03, 2025
pulisher
Apr 03, 2025

ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

A Tale of Resilience: ProPhase Labs Inc Amid Stock Market Turbulence - investchronicle.com

Apr 03, 2025
pulisher
Apr 03, 2025

ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strat - GuruFocus

Apr 03, 2025
pulisher
Apr 01, 2025

ProPhase Labs Delays Yearly Report Filing - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Prophase Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 01, 2025
pulisher
Apr 01, 2025

ProPhase Labs, Inc. SEC 10-K Report - TradingView

Apr 01, 2025

Prophase Labs Inc Azioni (PRPH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research DGX
$174.50
price up icon 0.81%
diagnostics_research WAT
$343.98
price down icon 1.51%
diagnostics_research LH
$246.59
price down icon 1.03%
$158.47
price up icon 0.52%
diagnostics_research MTD
$1,138.41
price down icon 1.54%
diagnostics_research IQV
$139.15
price down icon 0.86%
Capitalizzazione:     |  Volume (24 ore):